NCT01230736

Safety and Efficacy of Changing to DuoTrav From Prior Therapy

Assessing the Safety and Efficacy of Changing to DuoTrav® (Travoprost 0.004%/Timolol 0.5% Fixed Combination) as Replacement Therapy in Patients Uncontrolled on Bimatoprost 0.03%/Timolol 0.5% Therapy (Fixed or Unfixed)

• Status: Completed
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 105 (actual)
• Sponsor: Alcon Research · Industry
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this study to assess the safety and efficacy of changing to DuoTrav® from prior bimatoprost 0.03%/timolol 0.5% (used concomitantly or in a fixed combination) pharmacotherapy in uncontrolled patients with open-angle glaucoma or ocular hypertension.

Conditions

• Glaucoma

Interventions

Type	Name	Description
DRUG	Travoprost 0.004%/Timolol 0.5% Fixed Combination eye drops solution (Duotrav®)	One drop in study eye(s) once daily for 8 weeks

Timeline

• Start date: 2010-10-01
• Primary completion: 2011-02-01
• Completion: 2011-02-01
• First posted: 2010-10-29
• Last updated: 2016-11-21

Locations

1 site across 1 country: Germany